{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT04421274",
      "OrgStudyIdInfo": {
        "OrgStudyId": "ScPHFPC-100306"
      },
      "Organization": {
        "OrgFullName": "Afﬁliated Hospital of North Sichuan Medical College",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction",
      "OfficialTitle": "Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction: Single-blind, Randomized Controlled Muticentre Trial",
      "Acronym": "Bmmsct"
    },
    "StatusModule": {
      "StatusVerifiedDate": "June 2020",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "May 1, 2008",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "July 10, 2010",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "July 15, 2011",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "May 14, 2020",
      "StudyFirstSubmitQCDate": "June 5, 2020",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "June 9, 2020",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "June 5, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "June 9, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Afﬁliated Hospital of North Sichuan Medical College",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Chinese PLA General Hospital",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Peking Union Medical College Hospital",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Beijing Tongren Hospital",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "To investigate the effect and safety of intracoronary autologous bone morrow mesenchymal stem cells (BM-MSCs) transplantation in patients with ST-segment elevation myocardial infarction（ STEMI） .",
      "DetailedDescription": "To investigate the safety of intra-coronary injection of autologous bone marrow mesenchymal stem cells (BM-MSCs) in patients with ST-segment elevation myocardial infarction and its effect on cardiac function and viable myocardium. We plan to include approximately 40 patients with ST-segment elevation myocardial infarction as a research object, and conduct a randomized, single-blind, parallel-controlled multi-center clinical trial. The patients were randomly divided into a BM-MSCs group and a control group, and were given the best drug treatment and percutaneous coronary intervention (PCI). The primary study endpoint was the change in myocardial metabolic activity 6 months after autologous BM-MSCs transplantation and the change in left ventricular ejection fraction (LVEF) at 12 months; The incidence of adverse events. The above indexes were evaluated by cardiac color echocardiography and single photon emission computed tomography (SPECT)."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Myocardial Infarction"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Myocardial infarction",
          "Mesenchymal stem cells",
          "Bone marrow",
          "Stem cells transplantation"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 2",
          "Phase 3"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Single",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "43",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "BM-MSCs group",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Receive the best medication, percutaneous coronary intervention, and bone marrow mesenchymal stem cells transfer(Intracoronary artery )",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Bone marrow mesenchymal stem cells transfer",
                "Drug: Best medical treatment",
                "Procedure: Percutaneous coronary intervention"
              ]
            }
          },
          {
            "ArmGroupLabel": "Control group",
            "ArmGroupType": "Sham Comparator",
            "ArmGroupDescription": "Receive the best medication, percutaneous coronary intervention",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Best medical treatment",
                "Procedure: Percutaneous coronary intervention"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Bone marrow mesenchymal stem cells transfer",
            "InterventionDescription": "Inject the BM-MSCs into the infarct-related arterial hypertension through the central cavity of the guide wire balloon catheter under the complete blockage of the target blood vessel. Each time the balloon continues to fill for 2 minutes to block blood flow, then resume perfusion for 2 minutes. The above process is repeated 6 ~ 8 times",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "BM-MSCs group"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Best medical treatment",
            "InterventionDescription": "Refer to the latest medication guidelines and give the best medication to the patients",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "BM-MSCs group",
                "Control group"
              ]
            }
          },
          {
            "InterventionType": "Procedure",
            "InterventionName": "Percutaneous coronary intervention",
            "InterventionDescription": "Percutaneous coronary intervention",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "BM-MSCs group",
                "Control group"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "changes in myocardial metabolic activity",
            "PrimaryOutcomeDescription": "changes in myocardial metabolic activity 6 months after transplantation of autologous BM-MSCs (SPET assay)",
            "PrimaryOutcomeTimeFrame": "Baseline + after 6 months"
          },
          {
            "PrimaryOutcomeMeasure": "Changes in left ventricular ejection fraction (LVEF)",
            "PrimaryOutcomeDescription": "Changes in left ventricular ejection fraction (LVEF) at 12 months after transplantation of autologous BM-MSCs.",
            "PrimaryOutcomeTimeFrame": "Baseline + after 12 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "incidence of cardiovascular events",
            "SecondaryOutcomeDescription": "incidence of cardiovascular events",
            "SecondaryOutcomeTimeFrame": "in 12 months after transplantation of autologous BM-MSCs"
          },
          {
            "SecondaryOutcomeMeasure": "overall mortality",
            "SecondaryOutcomeDescription": "overall mortality",
            "SecondaryOutcomeTimeFrame": "in 12 months after transplantation of autologous BM-MSCs"
          },
          {
            "SecondaryOutcomeMeasure": "adverse events at 12 months after transplantation of autologous BM-MSCs",
            "SecondaryOutcomeDescription": "adverse events at 12 months after transplantation of autologous BM-MSCs",
            "SecondaryOutcomeTimeFrame": "in 12 months after transplantation of autologous BM-MSCs"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nAge> 18 years old;\nDiagnosed acute ST-elevation myocardial infarction (STEMI)\nSTEMI onset <1 month\nSuccessful vascular remodeling, blood flow of infarct-related blood vessels recovered to TIMI level 3\nAll patients included in the study signed an informed consent form and promised to complete all follow-up plans\n\nExclusion Criteria:\n\nRefractory persistent ventricular tachycardia\nHigh cardiac block and no pacemaker control\nLiver or renal dysfunction (ALT>80U/ L, Cr> 440mmol / L)\nBleeding disorders, malignant tumors\nAutoimmune disease or any serious fatal disease\nContraindications for coronary intervention\nCombined with other heart disease: congenital heart Disease (ventricular deficiency, atrial deficient, patent ductus arteriosus and other congenital alformations),primary valvular disease, active myocarditis, pulmonary heart disease,hyperthyroidism, mucous edema heart disease and so on\nMental illness, no self-awareness, and no precise expression and cooperation",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "The Third Hospital of Mianyang",
            "LocationCity": "Mianyang",
            "LocationState": "Sichuan",
            "LocationZip": "0816",
            "LocationCountry": "China"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "33413636",
            "ReferenceType": "derived",
            "ReferenceCitation": "Zhang R, Yu J, Zhang N, Li W, Wang J, Cai G, Chen Y, Yang Y, Liu Z. Bone marrow mesenchymal stem cells transfer in patients with ST-segment elevation myocardial infarction: single-blind, multicenter, randomized controlled trial. Stem Cell Res Ther. 2021 Jan 7;12(1):33. doi: 10.1186/s13287-020-02096-6."
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No",
      "IPDSharingDescription": "Unfortunately, the research data is not shared"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000009203",
            "ConditionMeshTerm": "Myocardial Infarction"
          },
          {
            "ConditionMeshId": "D000072657",
            "ConditionMeshTerm": "ST Elevation Myocardial Infarction"
          },
          {
            "ConditionMeshId": "D000007238",
            "ConditionMeshTerm": "Infarction"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000007511",
            "ConditionAncestorTerm": "Ischemia"
          },
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000009336",
            "ConditionAncestorTerm": "Necrosis"
          },
          {
            "ConditionAncestorId": "D000017202",
            "ConditionAncestorTerm": "Myocardial Ischemia"
          },
          {
            "ConditionAncestorId": "D000006331",
            "ConditionAncestorTerm": "Heart Diseases"
          },
          {
            "ConditionAncestorId": "D000002318",
            "ConditionAncestorTerm": "Cardiovascular Diseases"
          },
          {
            "ConditionAncestorId": "D000014652",
            "ConditionAncestorTerm": "Vascular Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M11307",
            "ConditionBrowseLeafName": "Myocardial Infarction",
            "ConditionBrowseLeafAsFound": "Myocardial Infarction",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9434",
            "ConditionBrowseLeafName": "Infarction",
            "ConditionBrowseLeafAsFound": "Infarction",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M1072",
            "ConditionBrowseLeafName": "ST Elevation Myocardial Infarction",
            "ConditionBrowseLeafAsFound": "ST-segment Elevation Myocardial Infarction",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9695",
            "ConditionBrowseLeafName": "Ischemia",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11436",
            "ConditionBrowseLeafName": "Necrosis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5698",
            "ConditionBrowseLeafName": "Coronary Artery Disease",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M18658",
            "ConditionBrowseLeafName": "Myocardial Ischemia",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8571",
            "ConditionBrowseLeafName": "Heart Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16552",
            "ConditionBrowseLeafName": "Vascular Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC14",
            "ConditionBrowseBranchName": "Heart and Blood Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}